MA Jun, WU Sui-jing, DU Xin. Low-Dose lnterleukin-2 Immunotherapy Does Not Improve Outcome of Patients Age 60 Years and Older with Acute Myeloid Leukemia in First Complete Remission[J]. Journal of Evidence-Based Medicine, 2009, 9(5): 274-276. DOI: 10.3969/j.issn.1671-5144.2009.05.012
|
Citation:
|
MA Jun, WU Sui-jing, DU Xin. Low-Dose lnterleukin-2 Immunotherapy Does Not Improve Outcome of Patients Age 60 Years and Older with Acute Myeloid Leukemia in First Complete Remission[J]. Journal of Evidence-Based Medicine, 2009, 9(5): 274-276. DOI: 10.3969/j.issn.1671-5144.2009.05.012
|
MA Jun, WU Sui-jing, DU Xin. Low-Dose lnterleukin-2 Immunotherapy Does Not Improve Outcome of Patients Age 60 Years and Older with Acute Myeloid Leukemia in First Complete Remission[J]. Journal of Evidence-Based Medicine, 2009, 9(5): 274-276. DOI: 10.3969/j.issn.1671-5144.2009.05.012
|
Citation:
|
MA Jun, WU Sui-jing, DU Xin. Low-Dose lnterleukin-2 Immunotherapy Does Not Improve Outcome of Patients Age 60 Years and Older with Acute Myeloid Leukemia in First Complete Remission[J]. Journal of Evidence-Based Medicine, 2009, 9(5): 274-276. DOI: 10.3969/j.issn.1671-5144.2009.05.012
|
DownLoad: